News
These three stocks are back on the radar as defence orders pick up. With multi-year order books and strong growth visibility, they’re poised to benefit—though valuations leave little room for error.
India is a major supplier of prescription drugs, over-the-counter medications, and pharmaceutical ingredients to the United ...
India's stock benchmarks erased intraday losses to settle flat on Thursday, as news of a U.S.-Russia presidential meeting ...
DSP MF launches India’s first passive Flexi Cap fund: Here's what differentiates it from active fund
The fund is based on the Nifty500 Flexicap Quality 30 Index, developed in partnership with NSE. The index combines quality ...
An ETF that tracks stocks in India is struggling to rebound from its recent losing streak, after President Trump imposed 25% ...
India's equity benchmarks rose on Monday, led by gains in metals and IT stocks, as hopes of a U.S. rate cut outweighed ...
President Trump’s latest tariff hike hits a U.S. trading partner that ranks in the top 10, but barely. India, which now faces a 50% levy ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results